CME Group Inc. (CME) Price Target Raised to $145.00 at Wells Fargo & Company
CME Group Inc. (NASDAQ:CME) had its price objective boosted by stock analysts at Wells Fargo & Company from $130.00 to $145.00 in a research report issued to clients and investors on Wednesday. The brokerage currently has a “market perform” rating on the financial services provider’s stock. Wells Fargo & Company’s price target suggests a potential upside of 5.59% from the stock’s current price.
A number of other brokerages also recently commented on CME. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $127.00 target price on shares of CME Group in a report on Friday, July 14th. Citigroup Inc. started coverage on CME Group in a report on Wednesday, July 12th. They issued a “buy” rating and a $140.00 target price on the stock. Finally, Royal Bank Of Canada boosted their target price on CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 20th. One analyst has rated the stock with a sell rating, three have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $134.40.
CME Group (NASDAQ CME) traded down 0.3460% during trading on Wednesday, reaching $136.8548. The company’s stock had a trading volume of 414,302 shares. CME Group has a 52 week low of $98.95 and a 52 week high of $137.45. The firm has a 50-day moving average price of $129.65 and a 200-day moving average price of $122.92. The firm has a market capitalization of $46.52 billion, a P/E ratio of 27.9353 and a beta of 0.73.
CME Group (NASDAQ:CME) last released its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating the consensus estimate of $1.20 by $0.03. The business had revenue of $925.00 million during the quarter, compared to analyst estimates of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.14 earnings per share. On average, equities analysts anticipate that CME Group will post $4.83 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This story was first posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/10/04/cme-group-inc-cme-price-target-raised-to-145-00-at-wells-fargo-company.html.
In related news, Director Dennis Suskind sold 750 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $129.34, for a total transaction of $97,005.00. Following the transaction, the director now directly owns 5,059 shares of the company’s stock, valued at $654,331.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $124.50, for a total transaction of $311,250.00. Following the transaction, the chief financial officer now directly owns 38,495 shares in the company, valued at $4,792,627.50. The disclosure for this sale can be found here. Insiders have sold 48,244 shares of company stock worth $6,021,890 over the last three months. 0.57% of the stock is owned by insiders.
A number of hedge funds have recently added to or reduced their stakes in the business. Beacon Capital Management purchased a new position in shares of CME Group during the 4th quarter valued at $0. Huntington National Bank raised its holdings in shares of CME Group by 4.7% during the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after acquiring an additional 38 shares in the last quarter. Johnson Financial Group Inc. raised its holdings in shares of CME Group by 5.9% during the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the financial services provider’s stock worth $104,000 after acquiring an additional 50 shares in the last quarter. Fiduciary Trust Co. purchased a new stake in shares of CME Group during the second quarter worth $105,000. Finally, Coconut Grove Bank raised its holdings in shares of CME Group by 95.7% during the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock worth $107,000 after acquiring an additional 440 shares in the last quarter. Institutional investors own 82.64% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.